Ethics briefings

Proxy consent for the involvement of incapacitated adults in drug trials was discussed in a previous ethics briefing on the implementation of the EU Clinical Trials Directive.1 In 2003, the BMA expressed concern about the piecemeal introduction of proxy decision making, prior to the introduction of...

Full description

Saved in:  
Bibliographic Details
Authors: English, Veronica (Author) ; Mussell, Rebecca (Author) ; Sheather, Julian (Author) ; Sommerville, Ann (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2004
In: Journal of medical ethics
Year: 2004, Volume: 30, Issue: 4, Pages: 421-422
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)

MARC

LEADER 00000naa a22000002 4500
001 1816126934
003 DE-627
005 20220908053400.0
007 cr uuu---uuuuu
008 220908s2004 xx |||||o 00| ||eng c
035 |a (DE-627)1816126934 
035 |a (DE-599)KXP1816126934 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a English, Veronica  |e VerfasserIn  |4 aut 
245 1 0 |a Ethics briefings 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Proxy consent for the involvement of incapacitated adults in drug trials was discussed in a previous ethics briefing on the implementation of the EU Clinical Trials Directive.1 In 2003, the BMA expressed concern about the piecemeal introduction of proxy decision making, prior to the introduction of more wide ranging mental incapacity legislation. In May 2004, this was echoed by the House of Lords in ongoing debate about the Medicines for Human Use (Clinical Trials) Regulations.2 It also became clear that the forthcoming Mental Capacity Act (formerly the Mental Incapacity Bill) would provide a proxy consent mechanism for strictly controlled research on incapacitated adults. In late 2003, a joint lords and commons committee scrutinising the draft incapacity bill recommended that “a clause be included to explore the causes and consequences of mental incapacity and to develop effective treatment for such conditions”.3 The government accepted this proposal and consulted stakeholders about its potential scope and appropriate safeguards. The act is expected to permit a range of research including studies on health and social care, subject to approval by research ethics committees. It may also amend the Human Tissue Bill to permit research on residual tissue taken from incapacitated people for diagnosis or therapy. Research must, however, relate to conditions affecting only incapacitated people in circumstances where there is no possibility of involving competent adults. Not only research expected to benefit the incapacitated individual, will be permitted: the act is also likely to allow research primarily intended to benefit others with the same condition, as long as it presents only minimal risk. It remains to be seen, however, how the medicinal trials regulations and the capacity act create joined up rules in this first attempt to introduce legally recognised proxy decision making in England and Wales. It is … 
700 1 |a Mussell, Rebecca  |e VerfasserIn  |4 aut 
700 1 |a Sheather, Julian  |e VerfasserIn  |4 aut 
700 1 |a Sommerville, Ann  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 30(2004), 4, Seite 421-422  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:30  |g year:2004  |g number:4  |g pages:421-422 
856 |3 Volltext  |u http://www.jstor.org/stable/27719250  |x JSTOR 
856 4 0 |u http://jme.bmj.com/content/30/4/421.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185580789 
LOK |0 003 DE-627 
LOK |0 004 1816126934 
LOK |0 005 20220908053400 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-02#511FEF37315FF4C15AA3C8116F02DFCECCD8071D 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/27719250 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw